Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

about

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

Item

http://www.wikidata.org/entity/Q38791220

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

@en

type

Item

label

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

@en

prefLabel

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

@en

P1476

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

@en

P2093

Jeanne M DeCara

http://www.w3.org/2001/XMLSchema#string

Karima Addetia

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

P2888

s11936-016-0458-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11936-016-0458-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27020051

http://www.w3.org/2001/XMLSchema#string

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

about

Cardiac Complications of HER2-Targeted Therapies in Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698